Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Amino Acids and Derivatives >  BOC-amino acid >  BOC-IMINODIACETIC ACID

BOC-IMINODIACETIC ACID

Basic information Safety Supplier Related

BOC-IMINODIACETIC ACID Basic information

Product Name:
BOC-IMINODIACETIC ACID
Synonyms:
  • RARECHEM EM WB 0140
  • N-BOC-IMINODIACETIC ACID
  • BOC-IDA
  • BOC-IDA-OH
  • BOC-IMINODIACETIC ACID
  • 2,2'-((tert-Butoxycarbonyl)azanediyl)diacetic acid
  • N-(tert-Butoxycarbonyl)iminodiacetic Acid
  • N-Boc-iminodiacetic acid >=96.0% (HPLC)
CAS:
56074-20-5
MF:
C9H15NO6
MW:
233.22
Product Categories:
  • Glycine Derivatives
  • Peptide Synthesis
  • Unnatural Amino Acid Derivatives
Mol File:
56074-20-5.mol
More
Less

BOC-IMINODIACETIC ACID Chemical Properties

Melting point:
117-120 °C
Boiling point:
412.0±38.0 °C(Predicted)
Density 
1.316±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
Methanol
form 
Powder
pka
3.45±0.10(Predicted)
color 
White
BRN 
4435233
More
Less

Safety Information

Safety Statements 
22-24/25
WGK Germany 
3
HazardClass 
IRRITANT
HS Code 
29241990

MSDS

More
Less

BOC-IMINODIACETIC ACID Usage And Synthesis

Chemical Properties

White crystalline

Uses

Building block for preparing chemical libraries

Uses

Boc-Iminodiacetic Acid can be used as a novel α4β7 integrin peptide antagonists.

Synthesis

24424-99-5

142-73-4

56074-20-5

General procedure: A mixture of iminodiacetic acid (5.1 g, 38.3 mmol) and sodium bicarbonate (NaHCO3, 12.9 g, 153 mmol) was dissolved in 50 mL of water. After the gas release stopped, 50 mL of tetrahydrofuran (THF) was added, followed by the slow addition of di-tert-butyl dicarbonate (Boc2O, 10.0 g, 46.0 mmol). The reaction mixture was stirred at room temperature for 2 days and the progress of the reaction was monitored by electrospray ionization mass spectrometry (ESI-MS) until complete consumption of the feedstock. Upon completion of the reaction, THF was removed by rotary evaporation and the aqueous phase was washed twice with ether (Et2O). Subsequently, the pH of the aqueous phase was adjusted with concentrated hydrochloric acid to 1. The product was extracted with ethyl acetate (EtOAc), and after combining the organic phases, the solvent was removed by rotary evaporation to give a white solid product. The product was further purified by recrystallization from ethyl acetate to give N-Boc-iminodiacetic acid (8.04 g, 90% yield) as clear crystals.ESI-MS detection showed [M-H]- peak at m/z 232.1.

References

[1] Journal of Medicinal Chemistry, 1996, vol. 39, # 8, p. 1601 - 1608
[2] Patent: WO2004/35576, 2004, A2. Location in patent: Page 170
[3] Patent: WO2005/117904, 2005, A2. Location in patent: Page/Page column 404-405
[4] Tetrahedron, 1996, vol. 52, # 29, p. 9793 - 9804
[5] Bioorganic and Medicinal Chemistry, 1998, vol. 6, # 8, p. 1347 - 1378

BOC-IMINODIACETIC ACIDSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com
Ark Pharm, Inc.
Tel
847-367-3680
Email
sales@arkpharminc.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Jia Xing Isenchem Co.,Ltd
Tel
0573-85285100 18627885956
Email
isenchem@163.com
More
Less